The trademark application STRANDDX was filed by Linus Biotechnology Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 30, 2022, and it was registered by office on October 7, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Medical diagnostic kits comprising reagents to be used in exposomic testing
Medical diagnostic kits comprised of reagents for diagnosing autism spectrum disorder (asd), attention deficit hyperactive disorder (adhd), amyotrophic lateral sclerosis (als), psychosis, schizophrenia, inflammatory bowel disease (ibs), eosinophilic esophagitis, renal disease, and cancer
Medical diagnostic reagents and assays for testing hair samples.
The mark was filed in class 10 with following description of goods:
Medical apparatus for use in exposomic testing
Apparatus for analysis of hair samples for diagnostic purposes
Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of autism spectrum disorder (asd), attention deficit hyperactive disorder (adhd), amyotrophic lateral sclerosis (als), psychosis, schizophrenia, inflammatory bowel disease (ibs), eosinophilic esophagitis, renal disease, and cancer
Medical devices for testing hair samples for diagnostic purposes
Diagnostic kits comprised of a test tube for specimen collection and a requisition form for use with an analysis device for testing hair samples for diagnosis of autism spectrum disorder (asd), attention deficit hyperactive disorder (adhd), amyotrophic lateral sclerosis (als), psychosis, schizophrenia, inflammatory bowel disease (ibs), eosinophilic esophagitis, renal disease, and cancer.
The mark was filed in class 42 with following description of goods:
Medical and scientific research
Medical research in the fields of autism spectrum disorder (asd), attention deficit hyperactive disorder (adhd), amyotrophic lateral sclerosis (als), psychosis, schizophrenia, inflammatory bowel disease (ibs), eosinophilic esophagitis, renal disease, and cancer
Laboratory research in the fields of autism spectrum disorder (asd), attention deficit hyperactive disorder (adhd), amyotrophic lateral sclerosis (als), psychosis, schizophrenia, inflammatory bowel disease (ibs), eosinophilic esophagitis, renal disease, and cancer
Genetic testing for medical and scientific research purposes.
The mark was filed in class 44 with Medical diagnostic services and medical testing for diagnostic purposes in the fields of autism spectrum disorder (asd), attention deficit hyperactive disorder (adhd), amyotrophic lateral sclerosis (als), psychosis, schizophrenia, inflammatory bowel disease (ibs), eosinophilic esophagitis, renal disease, and cancer..